/au/about-us/investor-centre/asx-announcements/
en/about-us/investor-centre/asx-announcements/
https://somnomed.com/en
https://somnomed.com/au/about-us/investor-centre/asx-announcements/
https://somnomed.com/au/about-us/investor-centre/asx-announcements/
about-us/investor-centre/asx-announcements/
WP_Post Object ( [ID] => 28453 [post_author] => 38 [post_date] => 2018-07-01 23:32:51 [post_date_gmt] => 2018-07-02 04:32:51 [post_content] => [vc_row el_class="product-range-banner"][vc_column][vc_single_image image="28435" img_size="full" css=".vc_custom_1530494403032{padding-top: 50px !important;}"][/vc_column][/vc_row][vc_row el_class="product-range-one"][vc_column][vc_column_text css=".vc_custom_1530499470473{padding-bottom: 20px !important;}"]SomnoMed Limited’s shares are listed on the Australian Securities Exchange.[/vc_column_text][vc_row_inner css=".vc_custom_1516358295451{padding-top: 10px !important;padding-bottom: 35px !important;}"][vc_column_inner][vc_column_text] 2019 Annual Report 2018 Annual Report 2017 Annual Report 2016 Annual Report 2015 Annual Report 2014 Annual Report 2013 Annual Report 2012 Annual Report 2011 Annual Report 2010 Annual Report[/vc_column_text][vc_column_text][/vc_column_text][/vc_column_inner][/vc_row_inner][vc_column_text css=".vc_custom_1570676416052{padding-top: 5px !important;padding-bottom: 20px !important;}"][su_spoiler title="ASX announcements – Q2 2020 (October 2019 - December 2019)" style="fancy" icon="caret"] Notice of AGM of SomnoMed 2019 SomnoMed Proxy 2019 [/su_spoiler][/vc_column_text][vc_column_text css=".vc_custom_1567390651337{padding-top: 5px !important;padding-bottom: 20px !important;}"][su_spoiler title="ASX announcements – Q1 2020 (July 2019 - September 2019)" style="fancy" icon="caret"] SOM Wilsons July 2019 AUS SOM 190821 - Muddy result clearer outlook SOM Wilsons September 2019 [/su_spoiler][/vc_column_text][vc_column_text css=".vc_custom_1567389795461{padding-top: 5px !important;padding-bottom: 20px !important;}"][su_spoiler title="ASX announcements – Q4 2019 (April 2019 - June 2019)" style="fancy" icon="caret"] SOM Preliminary Accounts FY19 Appendix 4C Q4 FY2019 Investor Presentation FY2019 [/su_spoiler][/vc_column_text][vc_column_text css=".vc_custom_1567059349272{padding-top: 5px !important;padding-bottom: 20px !important;}"][su_spoiler title="ASX announcements – Q3 2019 (January 2019 - March 2019)" style="fancy" icon="caret"] [/su_spoiler][/vc_column_text][vc_column_text css=".vc_custom_1567389297142{padding-top: 5px !important;padding-bottom: 20px !important;}"][su_spoiler title="ASX announcements – Q2 2019 (October 2018 - December 2018)" style="fancy" icon="caret"] Appendix 3B 3.10.18 - New issue announcement Appendix 3B 19th November 2018a ASX Announcement 19.11 - Change in Leadership of SomnoMed NVA CEO Key Terms 19.11 ASX Announcement AGM November 2018 AGM 2018 addresses 27.11.18 AGM Results for ASX 2018 Appendix 4C Q2 FY2019 [/su_spoiler][/vc_column_text][vc_column_text css=".vc_custom_1567389181492{padding-top: 5px !important;padding-bottom: 20px !important;}"][su_spoiler title="ASX announcements – Q1 2019 (July 2018 - September 2018)" style="fancy" icon="caret"] Appendix 3X – Initial Director’s Interest Notice Appendix 4C Q1 FY2019 [/su_spoiler][/vc_column_text][vc_column_text css=".vc_custom_1567389360537{padding-top: 5px !important;padding-bottom: 20px !important;}"][su_spoiler title="ASX Announcements – Q4 2018 (April 2018 - June 2018)" style="fancy" icon="caret"] AGM Results for ASX 2018 SomnoMed Proxy 2018 Appendix 4C Q3 FY2019 [/su_spoiler][/vc_column_text][vc_column_text css=".vc_custom_1530496324540{padding-top: 20px !important;padding-left: 0px !important;}"][su_spoiler title="ASX Announcements – Q3 2018 (January 2018 – March 2018)" style="fancy" icon="caret"] SOM Wilsons March 2018 Appendix 3Y Change of Director’s Interest Notice (RS) March 18 Appendix 3Y Change of Director’s Interest Notice (LA) March 18 TDM – Substantial Shareholder Notice 2018.03.22 Shareholding distribution – Analysis of Holdings as at 22-03-2018 SomnoMed – Appendix 3B 22.3.18 Retail Entitlements Appendix 3Y Change of Director’s Interest Notice Feb 18 Announcement of Dispatch of Entitlement Offer – 26.2.18 SomnoMed – Appendix 3B 27.2.18 Institutional Entitlements Confirmation of Release – SOM – Ceasing to be a substantial holder from AEF SomnoMed – Announcement of Entitlement Offer 18.2.18 – Clean Somnomed – Appendix 3B -19.2.18 SomnoMed – Cleansing Notice 18.2.18 – Clean SomnoMed – Ineligible Shareholders Letter 18.2.18 Trading Halt – 19 February 2018 SomnoMed – Retail Entitlement Offer Booklet 20.2.18 SomnoMed – Results of Institutional Offer 20.02.18 – ASX Lodgement SOM Feb 2018 Investors Presentation Final 18.02.18 ASX Lodgement [/su_spoiler][/vc_column_text][vc_column_text css=".vc_custom_1530496505412{padding-top: 40px !important;padding-left: 0px !important;}"][su_spoiler title="ASX Announcements – Q2 2018 (October 2017 – December 2017)" style="fancy" icon="caret"] ASXQ1 Oct 17 Final Cleana SomnoMed Appendix 4C September 2017 final AGM Results for ASX 2017 ASX Announcement Q2 FY18 ASX SomnoMed Appendix 4C December 2017ASX AGM Results for ASX 2017 Som Appendix 3B – 5.10.2017 Som Appendix 3Y Notice of AGM of SomnoMed 2017 SomnoMed Proxy 2017 [/su_spoiler][/vc_column_text][vc_column_text css=".vc_custom_1530496594861{padding-top: 40px !important;padding-left: 0px !important;}"][su_spoiler title="ASX Announcements – Q1 2018 (July 2017 – September 2017)" style="fancy" icon="caret"] SomAppendix 3B12.9.17 TDM Substancial Shareholder Notice SOM 08.09.2017 SomnoMed (SOM) | BUY: RSS network shaping up nicely 28.08.2017 [/su_spoiler][/vc_column_text][vc_column_text css=".vc_custom_1530496726252{padding-top: 40px !important;padding-left: 0px !important;}"][su_spoiler title="ASX Announcements – Q4 2017 (April 2017 – June 2017)" style="fancy" icon="caret"] SomnoMed FY17 Investors Presentation 24.08.2017 SOM Preliminary Accounts FY17 24.08.2017 TDM Substantial Shareholder Notice SOM – 12.5.17 Renew Sleep Solutions well ahead of plan – 26.4.17 Appendix 4C Quarterly report for entities subject to Listing Rule 4.7B – 26.4.17 [/su_spoiler][/vc_column_text][vc_column_text css=".vc_custom_1530496769082{padding-top: 40px !important;padding-left: 0px !important;}"][su_spoiler title="ASX Announcements – Q3 2017 (January 2017 – March 2017)" style="fancy" icon="caret"] SomnoMed Sleeping beauty, Morgans CIMB – 23.2.17 SomnoMed HFY17 – 23.2.17 [/su_spoiler][/vc_column_text][vc_column_text css=".vc_custom_1530496846933{padding-top: 40px !important;padding-left: 0px !important;}"][su_spoiler title="ASX Announcements – Q2 2017 (October 2016 – December 2016)" style="fancy" icon="caret"] SomnoMed HY Accounts – 31.12.16 SOM Wilsons October 2016 SomAppendix 3B7.10.16 SomnoMed Proxy 2016 Notice of AGM of SomnoMed 2016 [/su_spoiler][/vc_column_text][vc_column_text css=".vc_custom_1530497043779{padding-top: 40px !important;padding-left: 0px !important;}"][su_spoiler title="ASX Announcements – Q1 2017 (July 2016 – September 2016)" style="fancy" icon="caret"] FDA 510k Approval for SomnoDent – 29.9.16 SomAppendix 3B 1.9.16 TDM SSH 26.8.16 – Form 604, Notice of change of interests of substantial holder SomAppendix 3B 25.8.16 SOMApp3YPN 26.8.16 Form 605 Neustadt Shares 26.8.16 SomnoMed FY16 Presentation SOM Preliminary Accounts FY16 Q4 ASX June 2016 Quarter Final 603 Initial Form SomnoMed Ltd – July 2016 SOM Appendix 4C – Quarterly Report for Entities Admitted on the Basis of Commitments Derek Smith appointed Global CEO of SomnoMed CEO appointed for new direct to patient business entity [/su_spoiler][/vc_column_text][vc_column_text css=".vc_custom_1530497232920{padding-top: 40px !important;padding-left: 0px !important;}"][su_spoiler title="ASX Announcements - Q4 2016 (April 2016 - June 2016)" style="fancy" icon="caret"] Wilson HTM Equity Research - SOM - 1 June 2016 Appendix 03Y Change of Director’s Interest Notice June 2016 Appendix 03Y PN Change of Director’s Interest Notice June 2016 Appendix 03Y LA Change of Director’s Interest Notice June 2016 Results of Retail entitlement offer: 1 June 16 Shareholding Info 6.6.2016 Form 604- Notice of change of interests of substantial holder 6 June 2016 SomnoMed - Appendix 3B - 6 June 2016 SomnoMed - Appendix 3B - 13 May 2016 Announcement of Dispatch of Entitlement Offer - May 2016 SomnoMed - Results of Institutional Offer - FINAL May 2016 SomnoMed - Ineligible Shareholders Letter - May 2016 Announcement of Entitlement Offer - May 2016 Cleansing Notice - May 2016 SOM Investors Presentation FINAL May 2016 SOM Chair Letter May 2016 SOM- Appendix 3B - May 2016 SomnoMed - Ineligible Shareholders Letter - May 2016 SOM Appendix 3B - April 2016 [/su_spoiler][/vc_column_text][vc_column_text css=".vc_custom_1530497314306{padding-top: 40px !important;padding-left: 0px !important;}"][su_spoiler title="ASX Announcements - Q3 2016 (January 2016 - March 2016)" style="fancy" icon="caret"] SOM Appendix  4C - March 2016 SomnoMed HY Accounts at 31 December 2015 SOM Investor Presentation February 2016 SOMNOMED RECORDS 30% GROWTH IN DIRECT SALES REVENUES OF SOMNODENT® DEVICES IN 1ST HALF OF 2015/16 SOM Appendix 4C Becoming a substantial holder [/su_spoiler][/vc_column_text][vc_column_text css=".vc_custom_1530497363074{padding-top: 40px !important;padding-left: 0px !important;}"][su_spoiler title="ASX Announcements - Q2 2016 (October 2015 - December 2015)" style="fancy" icon="caret"] FROST & SULLIVAN RECOGNISES SOMNOMED LIMITED AS OBSTRUCTIVE SLEEP APNEA COMPANY OF THE YEAR AT THE ANNUAL AUSTRALIAN EXCELLENCE AWARDS Appendix 3YPN AGM Results for ASX 2015 SOM Appendix 3B SOM Appendix 3B6 SomnoMed acquires Strong Dental, Canada SOM Appendix 3YLA SOM Appendix 3YPN SOM Appendix 3B SomnoMed exceeds 250,000 patients SomnoMed  Proxy 2015 Notice of AGM  of SomnoMed 2015 SOM Appendix 3B GROWTH ACCELERATION IN THE US LEADS TO NEW RECORD QUARTER [/su_spoiler][/vc_column_text][vc_column_text css=".vc_custom_1530497398816{padding-top: 40px !important;padding-left: 0px !important;}"][su_spoiler title="ASX Announcements - Q1 2016 (July 2015 - September 2015)" style="fancy" icon="caret"] Preliminary Final report 2015 SomnoMed Investor Presentation August 2015 ASX Release SOM Appendix 4C SomnoMed Appendix 4G September 2015 New Investor Form 603_090915 SomnoMed Appendix 3B_July 2015 SomnoMed Announcement - Strong Finish to Financial Year - July 2015 [/su_spoiler][/vc_column_text][vc_column_text css=".vc_custom_1530497441870{padding-top: 40px !important;padding-left: 0px !important;}"][su_spoiler title="ASX Announcements - Q4 2015 (April 2015 - June 2015)" style="fancy" icon="caret"] SomnoMed Appendix 4C June 2015 Quarter DentitracFDA ASX Jun2015 Ceasing to be a Substantial holder_July 2015 SomnoMed Update May 2015 Announcement: SOMNOMED TO ACQUIRE 100% OF SMH BIOMATERIAL AG  Appendix 3B [/su_spoiler][/vc_column_text][vc_column_text css=".vc_custom_1530497479402{padding-top: 40px !important;padding-left: 0px !important;}"][su_spoiler title="ASX Announcements - Q3 2015 (January 2015 - March 2015)" style="fancy" icon="caret"] Continuous Growth of SomnoMed in Third Quarter Appendix 4C Quarterly (Q3) Ceasing to be a substantial shareholder Addition of SomnoMed to Australian All Ordinaries Index  Ceasing to be a substantial shareholder Appendix 3B New issue announcement Appendix 4D and Half-Year Financial Review Investor Presentation: Financial Year 2014-2015 Half Year Review SomnoMed Achieves Growth Targets Appendix 3B New Issue Announcement January 2015 Appendix 4C Quarterly [/su_spoiler][/vc_column_text][vc_column_text css=".vc_custom_1530497554318{padding-top: 40px !important;padding-left: 0px !important;}"][su_spoiler title="ASX Announcements - Q2 2015 (October 2014 - December 2014)" style="fancy" icon="caret"] Form 604 TDM Asset Management December 2014 Appendix 3B New Issue Announcement December 2014 Appendix 3YRS December 2014 - Change of Director's Interest Notice Appendix 3YLA - Change of Director's Interest Notice Appendix 3YPN - Change of Director's Interest Notice Appendix 3YRS - Change of Director's Interest Notice Form 604 Belgove December 2014 Appendix 3B New Issue Announcement: application for quotation of additional securities and agreement Annual Meeting Minutes SOM Shareholder Change Form Form 604 SomnoMed Exceeds 200,000 Patients ASX Investor Presentation November 2014 SomnoMed Limited (SOM) Q1 Stock Analysis, Morgans CIMB SomnoMed Limited (SOM) Q1 Stock Analysis, Wilson HTM Notice of Annual General Meeting SomnoMed Limited Proxy Form Appendix 3B - New issue announcement,application for quotation of additional securities and agreement New Records in September Confirm Guidance (ASX:SOM) Appendix 4C - Quarterly report for entities admitted on the basis of commitments  [/su_spoiler][/vc_column_text][vc_column_text css=".vc_custom_1530497593560{padding-top: 40px !important;padding-left: 0px !important;}"][su_spoiler title="ASX Announcements - Q1 2015 (July 2014 - September 2014)" style="fancy" icon="caret"] US Medicare reimbursement approval granted for SOMNODENT® Herbst Advance  Appendix 3B New issue announcement SOM:ASX 2014 SHARE PURCHASE PLAN – CLOSES OVERSUBSCRIBED SomnoMed ("SOM"-ASX) Preliminary final report – 30 June 2014 SOM - Investor Presentation FY14 Appendix 3YLA - Change of Director’s Interest Notice Appendix 3Y - Change of Director’s Interest Notice SOM - Change in Substantial Holding SomnoMed ("SOM"-ASX) Share Placement Update SomnoMed SOM 708A Cleansing SomnoMed Limited Appendix 3B - New Issue Announcement SomnoMed (SOM) Research SomnoMed Italy [/su_spoiler][/vc_column_text][vc_column_text css=".vc_custom_1530497646818{padding-top: 40px !important;padding-left: 0px !important;}"][su_spoiler title="ASX Announcements - Q4 2014 (April 2014 - June 2014)" style="fancy" icon="caret"] Appendix 3B_New Issue Annoucement_June 2014 SomnoMed Appendix 4C_June 2014 SomnoMed Q4 Final SomnoDent Fusion 510k_June 14 SomnoMed Launches New Products at AADSM SomnoMed - Spain SomnoMed Enters the UK Appendix 3B_New Issue Announcement Form 604_Notice of Change of interests of substantial holder [/su_spoiler][/vc_column_text][vc_column_text css=".vc_custom_1530497683426{padding-top: 40px !important;padding-left: 0px !important;}"][su_spoiler title="ASX Announcements – Q3 2014 (January 2014-March 2014)" style="fancy" icon="caret"] Appendix 4C_Quarterly report Notice of ceasing to be a substantial holder Notice of change of interest of substantial holder SomnoMed Growth_Q3 Notice of ceasing to be a substantial holder SomnoMed Growth_Q3 [/su_spoiler][/vc_column_text][vc_column_text css=".vc_custom_1530497716691{padding-top: 40px !important;padding-left: 0px !important;}"][su_spoiler title="ASX Announcements – Q2 2014 (October 2013-December 2013)" style="fancy" icon="caret"] Appendix 3B_New Issue Announcement Appendix 3B_New Issue announcement Appendix 3Y_Change of Director's Interest Appendix 4C_Quarterly Report Continuing Global Growth for SomnoMed Exclusive Agreement Signed for Compliance Measurement SomnoMed Acquired 2nd Largest OA Company in France SomnoMed General Meeting_Nov12 [/su_spoiler][/vc_column_text][vc_column_text css=".vc_custom_1530497757003{padding-top: 40px !important;padding-left: 0px !important;}"][su_spoiler title="ASX Announcements – Q1 2014 (July 2013-September 2013)" style="fancy" icon="caret"] Appointment of New US Head Appointment of new VP managed care Burkhart Partnership Announcement SomnoMed Continues to break records in 4th quarter Appendix 3B New Issue Announcement Appendix 4C Quarterly Report SomInvestor Presentation Sept 2012 FINAL Preliminary Final Report [/su_spoiler][/vc_column_text][vc_row_inner css=".vc_custom_1526357097254{padding-top: 10px !important;padding-bottom: 10px !important;}"][vc_column_inner][vc_column_text css=".vc_custom_1530499391213{padding-top: 30px !important;}"]Every State in the United States of America, and most countries throughout the world have their own laws regulating the types of securities and other investment products which maybe offered to their residents, as well as the process for doing so. As a result, investment in some securities is not available to every interested investor. Accordingly, this information is provided for informational purposes only, and does not constitute an offer or solicitation to buy or sell Somnomed Limited shares in any jurisdiction where such would be prohibited. All investments involve different degrees of risk. In making any investment you should be aware of your risk tolerance level and financial situations at all times. Furthermore, you should seek professional investment advice before making any investment decisions. Somnomed Limited and/or its shareholders, directors, officers and/or employees make no investment recommendations in respect to any investment made in Somnomed Limited.[/vc_column_text][/vc_column_inner][/vc_row_inner][vc_row_inner][vc_column_inner][/vc_column_inner][/vc_row_inner][vc_row_inner][vc_column_inner][/vc_column_inner][/vc_row_inner][vc_row_inner][vc_column_inner][/vc_column_inner][/vc_row_inner][/vc_column][/vc_row] [post_title] => ASX Announcements and Annual Reports [post_excerpt] => [post_status] => publish [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => asx-announcements [to_ping] => [pinged] => [post_modified] => 2019-10-09 21:55:23 [post_modified_gmt] => 2019-10-10 02:55:23 [post_content_filtered] => [post_parent] => 28407 [guid] => https://somnomed.com/?page_id=28453 [menu_order] => 1 [post_type] => page [post_mime_type] => [comment_count] => 0 [filter] => raw )